AI assistant
Sending…
Sopharma AD — Earnings Release 2023
May 22, 2023
2543_rns_2023-05-22_a049fd41-cf93-4406-91cf-aa76be8e1e80.pdf
Earnings Release
Open in viewerOpens in your device viewer
Current report №24/2023 Dated May 22, 2023
NOTIFICATION
"Sopharma" AD (the Company) notifies that for April 2023 the Company realized a decrease in sales of 22% compared to the same month of the previous year, including 5% decrease of domestic sales and 31% decrease of export sales.
For the four months of 2023, sales increased by a total of 24% - maintaining domestic sales and 47% growth of export sales.
Ognian Donev
More from Sopharma AD
Transaction in Own Shares
2026
Jun 1
Regulatory Filings
2026
May 29
Transaction in Own Shares
2026
May 29
Transaction in Own Shares
2026
May 28
Transaction in Own Shares
2026
May 27
Transaction in Own Shares
2026
May 26
Transaction in Own Shares
2026
May 22
Regulatory Filings
2026
May 21
Transaction in Own Shares
2026
May 21
Regulatory Filings
2026
May 20